18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA)
NCT ID: NCT04647214
Last Updated: 2025-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
220 participants
OBSERVATIONAL
2021-03-03
2024-07-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-term Safety and Efficacy Extension Trial of Bimatoprost SR
NCT03891446
Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension
NCT01915940
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT02250651
A Phase 3 Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia
NCT03857542
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
NCT01157364
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bimatoprost intracameral implant (DURYSTA) 10μg
Patients with OAG or OHT who are scheduled for intracameral administration of a bimatoprost intracameral implant by their ophthalmologist.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Concurrent or anticipated enrollment in an interventional clinical trial involving either an investigational medicinal product or medical device.
* Previous enrollment in another Allergan bimatoprost intracameral implant study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Allergan
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ALLERGAN INC.
Role: STUDY_DIRECTOR
Allergan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Angeles Eye Institute /ID# 240368
Culver City, California, United States
Hamilton Glaucoma Center Shiley Eye Center UCSD /ID# 240364
La Jolla, California, United States
American Institute of Research /ID# 247820
Los Angeles, California, United States
North Bay Eye Associates Inc. /ID# 240362
Petaluma, California, United States
Pacific Eye Associates /ID# 240536
San Francisco, California, United States
Colorado Eye Institute /ID# 240798
Colorado Springs, Colorado, United States
ICON Eye Care /ID# 240681
Grand Junction, Colorado, United States
Eye Associates of Fort Meyers /ID# 244476
Fort Myers, Florida, United States
MedEye Associates /ID# 240374
Miami, Florida, United States
Center for Sight - Sarasota /ID# 244578
Sarasota, Florida, United States
Newsom Eye & Laser Center /ID# 253287
Sebring, Florida, United States
Dr. Andrew Gardner Logan, FL /ID# 240361
Tamarac, Florida, United States
Your Eye Specialists /ID# 253286
Weston, Florida, United States
Georgia Eye Partners /ID# 240061
Atlanta, Georgia, United States
Kovach Eye Institute /ID# 244581
Elmhurst, Illinois, United States
Stiles Eyecare Excellence /ID# 240376
Overland Park, Kansas, United States
The Eye Care Institute /ID# 240367
Louisville, Kentucky, United States
John Hopkins Wilmer Eye Institute /ID# 243701
Bethesda, Maryland, United States
Midwest Vision Research Foundation at Pepose Vision Institute /ID# 240537
Chesterfield, Missouri, United States
Wiles Eye Center /ID# 240808
Kansas City, Missouri, United States
Ophthalmology Associates /ID# 240799
St Louis, Missouri, United States
Eye Associates of North Jersey /ID# 244585
Dover, New Jersey, United States
Hudson Eye /ID# 240805
Jersey City, New Jersey, United States
Glaucoma Care Center /ID# 252021
Livingston, New Jersey, United States
Burlington County Eye Physicians /ID# 244594
Willingboro, New Jersey, United States
MaculaCare PLLC /ID# 244593
New York, New York, United States
New York New Jersey Eye Institute /ID# 244590
Orangeburg, New York, United States
New York Eye Surgery Associates, PLLC /ID# 244592
The Bronx, New York, United States
Duke Eye Center /ID# 244478
Durham, North Carolina, United States
Bergstrom Eye Research LLC /ID# 240363
Fargo, North Dakota, United States
META Medical Research Institute, LLC /ID# 240800
Dayton, Ohio, United States
Oklahoma Eye Surgeons /ID# 240373
Oklahoma City, Oklahoma, United States
Scott and Christie and Associates /ID# 244574
Cranberry Township, Pennsylvania, United States
Vanderbilt University Medical Center /ID# 244577
Nashville, Tennessee, United States
Glaucoma Associates of Texas /ID# 240682
Dallas, Texas, United States
Glaucoma Associates of Texas /ID# 253289
Dallas, Texas, United States
El Paso Eye Surgeons, P.A. /ID# 240366
El Paso, Texas, United States
DCT Shah Eye Research Institut /ID# 240375
Mission, Texas, United States
The Eye Centers of Racine and Kenosha LTD /ID# 240059
Racine, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mann E, Kammer JA, Sawhney G, An J, Werts EC, Vera V, Rivas M, Lai H, Sonparote S, Craven ER. Prospective 18-Month Study of Bimatoprost Intracameral Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension in US Clinical Practice. Drugs. 2025 Mar;85(3):397-414. doi: 10.1007/s40265-025-02157-1. Epub 2025 Feb 13.
Related Links
Access external resources that provide additional context or updates about the study.
Clinical Study Report Synopsis
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MED-MA-EYE-0648
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.